IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death

Cell Death and Differentiation

Volumn 7, Issue 11, 2000, Pages 1109-1118

  Smith, J ^a   Goldsmith, C ^a   Ward, A ^b   Ledieu, R ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

Apoptosis; IGF II; Mdx; Muscular dystrophy; Programmed cell death; Survival factor

Indexed keywords

DYSTROPHIN; SOMATOMEDIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE FUNCTION; GENE LOSS; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MUSCLE CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0033678812     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400738     Document Type: Article

References (54)

1. Duchenne muscular dystrophy: Pathogenetic aspects and genetic prevention
2. Dystrophin: The protein product of the Duchenne muscular Dystrophy locus
3. Linkage relationship of a cloned DNA sequence on the short arm of the X-chromosome to Duchenne Muscular dystrophy
4. Immunoelectron microscope localisation of dystrophin in myofibers
5. Association of dystrophin and an integral membrane glycoprotein
6. Syntrophin binds to an alternatively spliced exon of dystrophin
7. Three muscular dystrophies: Loss of cytoskeleton-extracellular matrix linkage
8. Dystrophin as a mechanochemical transducer in skeletal muscle
9. Molecular and genetic mapping of the mouse mdx locus
10. Chromosome X-linked muscular dystrophy in the mouse
11. Dystrophin-glycoprotein complex: Molecular organisation and critical roles in skeletal muscle
12. 'Mdx' mouse myopathy: Histopathological, morphometric and histochemical observations on young mice
13. Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II
14. A noninvasive procedure to detect muscle weakness in the mdx mouse
15. Enhanced expression of transforming growth factor-betal during thyroid hyperplasia in rats
16. Acute infantile spinal muscular atrophy: Muscle apoptosis as a proposed pathogenetic mechanism
17. Therapeutic effects of IGF-2 on dystrophic skeletal muscle
18. Muscle growth factors, ubiquitin and apoptosis in dystrophic muscle: Apoptosis declines with age in the mdx mouse
19. Apoptosis precedes necrosis of dystrophin-deficient muscle
20. Visualisaton of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: Evidence of apoptosis in dystrophic deficient muscle
21. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the I kappa B alpha/NF-kappa B pathway in limb-girdle muscular dystrophy type 2A
22. Myotonic dystrophy muscle nuclei have features of apoptosis, 'apoptosis-lente', SPI accumulation and contain filamentous inclusions and ubiquitin immunoreactivity
23. Activation of caspase-3 apoptotic pathways in skeletal muscle fibres in laminin alpha-2 deficient mice
24. Gamma sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin
25. Dystrophic muscle in mice chimeric for expression of alpha 5 integrin
26. Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts
27. C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines
28. Insulin-like growth factors I and II prevent apoptosis in a human teratoma derived cell line
29. Disproportionate growth in mice with Igf-2 transgenes
30. Ontogeny of somatomedins during development in the mouse. Serum concentrations, molecular forms, binding proteins and tissue receptors
31. High Plasma insulin-like growth factor-II and low lipid content in transgenic mice: Measurements of lipid metabolism
32. In vivo muscle gene transfer of full length dystrophin with an adenoviral vector that lacks all viral genes
33. A potential replacement for dystrophin?
34. Reversal of terminal differentiation mediated by p 107 in Rb -/- muscle cells
35. pRB controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis
36. Use of normal daughters' and sisters' creatine kinase levels in estimating heterozygosity in Duchenne Muscular dystrophy
37. Motorneurons are altered in muscular dystrophy
38. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity
39. Programmed cell death and senescence in skeletal muscle stem cells
40. The molecular and biochemical basis of Duchenne muscular dystrophy
41. Genetic and biochemical normalisation in female carriers of dystrophin production in dystrophin-competent myonuclei
42. Conversion of mdx myofibers from dystrophin negative to positive by injection of normal myoblasts
43. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation
44. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy
45. Stable integration of an mdx skeletal muscle cell line into dystrophic (mdx) skeletal muscle: Evidence for stem cell status
46. Selection and use of ligands for receptor-mediated gene delivery to myogenic cells
47. Efficient muscle-specific transgene expression after adenovirus-mediated gene transfer in mice using a 1.35 kb muscle creatine kinase promoter/enhancer
48. Molecular and functional analysis of the utrophin promoter
49. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene
50. Induction of utrophin gene expression by heregulin in skeletal muscle cells role of the N-box motif and GA binding protein
51. Whole mount in situ hybridisation of vertebrate embryos
52. Sequence of a placental cDNA encoding the mouse insulin-like growth factor II precursor
53. The effects of fibroblast growth factors in long term primary culture of dystrophic (mdx) mouse muscle myoblasts
54. Evolution of insulin-like growth factor II: Characterization of the mouse IGF-II gene and identification of two pseuobexons